Searched for
FLUCONAZOLE INJECTION
Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Delhi police busts fake cancer drug racket: Here's how they sold Rs 100 drug for Rs 2 lakhThe Delhi Police have uncovered a massive fake drug operation in west Delhi’s Moti Nagar, involving the manufacturing and distribution of f...
- Medicine for bearish markets: 5 Indian pharma stocks with upside potential of up to 32%There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising ...
- Second & better attempt; 5 Indian pharma stocks with upside potential of up to 31%Both, in terms of bottomline and stock price performance, pharma stocks had been under pressure for a long time. Partly this under performa...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Claris Lifesciences surges on ANDA approvalStocks of Claris Lifesciences climbed over 4% after one of its existing shareholders sold out its entire stake in the company via a block d...
- Claris gets USFDA supplemental nod for Fluconazole injectionThe drug firm said it markets its products through a wholly-owned subsidiary Claris Lifesciences Inc.
- Antibiotics to insulin: Key drugs to cost 4% moreBesides, the govt regulates prices of all other medicines and companies are allowed to hike prices of such drugs by only up to 10% in a yea...
- Blood pressure drugs and antibiotics to be cheaper as government plans to notify price capsTop-selling blood pressure drugs and antibiotics could become a lot cheaper as the govt plans to notify price caps for 51 essential drugs
- Claris Life Sciences gets approval to market two anti-infectives injections in RussiaThe approval from Russia's Ministry of Health is to market two anti-infectives -- Fluconazole IV 100-ml and Levofloxacin IV 100-ml.
- Pfizer recalls drug from USPFIZER has recalled a drug made by an Indian partner from the US market while another local partner of the world’s largest drugmaker receiv...
Load More
